Literature DB >> 2964324

Carbohydrate and lipid metabolism of skeletal muscle in type 2 diabetic patients.

K Falholt1, I Jensen, S Lindkaer Jensen, H Mortensen, A Vølund, L G Heding, P Noerskov Petersen, W Falholt.   

Abstract

Peripheral hyperinsulinaemia is the cause of metabolic changes that might contribute to the high incidence of macrovascular disease in patients with diabetes mellitus. In order to test this hypothesis muscle biopsies from 12 Type 2 diabetic patients and 14 age and sex matched non-diabetic patients, undergoing minor surgery, were obtained. The diabetic patients had significantly elevated fasting serum insulin (0.29 +/- 0.05 vs 0.06 +/- 0.03 nmol-1) and glucose (8.3 +/- 1.5 vs 4.6 +/- 0.5 mmol-1) and HbA1 levels (8.4 +/- 0.4 vs 5.0 +/- 0.2 per cent). The fasting and 2-h postprandial C-peptide levels were 0.99 +/- 0.25 vs 0.39 +/- 0.12 and 3.12 +/- 0.75 vs 1.09 +/- 0.34 nmol/l, respectively. The diabetic patients showed a marked elevation of triglyceride in the striated muscle biopsies compared to the non-diabetic controls (290 +/- 52 vs 48 +/- 6 mumol/g wet weight, p less than 0.001). Moreover, the activities of glucose-6-phosphate dehydrogenase (0.25 +/- 0.03 vs 0.13 +/- 0.01 U/g wet weight) and malic enzyme (0.15 +/- 0.01 vs 0.05 +/- 0.01 U/g wet weight), necessary for lipid synthesis, were significantly increased (both p less than 0.001) in the diabetic patients while the glycolytic enzymes, hexokinase (0.65 +/- 0.09 vs 1.82 +/- 0.11 U/g wet weight), pyruvate kinase (7.3 +/- 0.9 vs 13.2 +/- 0.9 U/g wet weight), phosphofructokinase (1.3 +/- 0.2 vs 2.6 +/- 0.2 U/g wet weight), and alpha-glycerophosphate dehydrogenase (7.3 +/- 0.5 vs 12.5 +/- 0.7 U/g wet weight) were decreased (all p less than 0.001).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2964324     DOI: 10.1111/j.1464-5491.1988.tb00936.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  18 in total

Review 1.  Peroxisome proliferator activated receptors, fatty acids and muscle insulin resistance.

Authors:  Edward Kraegen; Gregory Cooney; Ji-Ming Ye; Stuart Furler
Journal:  J R Soc Med       Date:  2002       Impact factor: 5.344

2.  Studies on the mechanism of action of sulphonylureas in type II diabetic subjects: gliquidone.

Authors:  E Bonora; P Moghetti; M Querena; M Zenere; V Cacciatori; F Tosi; D Travia; G Zoppini; M Muggeo
Journal:  J Endocrinol Invest       Date:  1992-01       Impact factor: 4.256

3.  Technical evaluation of in vivo abdominal fat and IMCL quantification using MRI and MRSI at 3 T.

Authors:  Xiaojuan Li; Jack F Youngren; Ben Hyun; Giorgos K Sakkas; Kathleen Mulligan; Sharmila Majumdar; Umesh B Masharani; Morris Schambelan; Ira D Goldfine
Journal:  Magn Reson Imaging       Date:  2007-08-02       Impact factor: 2.546

4.  Variant sequences of the Hexokinase II gene in familial NIDDM.

Authors:  R W Taylor; R L Printz; M Armstrong; D K Granner; K G Alberti; D M Turnbull; M Walker
Journal:  Diabetologia       Date:  1996-03       Impact factor: 10.122

5.  Glucose-free fatty acid cycle operates in human heart and skeletal muscle in vivo.

Authors:  P Nuutila; V A Koivisto; J Knuuti; U Ruotsalainen; M Teräs; M Haaparanta; J Bergman; O Solin; L M Voipio-Pulkki; U Wegelius
Journal:  J Clin Invest       Date:  1992-06       Impact factor: 14.808

Review 6.  Pathogenesis of insulin resistance in skeletal muscle.

Authors:  Muhammad A Abdul-Ghani; Ralph A DeFronzo
Journal:  J Biomed Biotechnol       Date:  2010-04-26

7.  Lifestyle changes and lipid metabolism gene expression and protein content in skeletal muscle of subjects with impaired glucose tolerance.

Authors:  M Mensink; E E Blaak; H Vidal; T W A De Bruin; J F C Glatz; W H M Saris
Journal:  Diabetologia       Date:  2003-07-11       Impact factor: 10.122

8.  Effects of non-esterified fatty acids on insulin-stimulated glucose transport in isolated skeletal muscle from patients with type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  D Galuska; L Nolte; E Wahlström; J S Smedegaard Kristensen; H Wallberg-Henriksson; J R Zierath
Journal:  Acta Diabetol       Date:  1994-09       Impact factor: 4.280

Review 9.  Intracellular lipid accumulation in liver and muscle and the insulin resistance syndrome.

Authors:  Cristina Lara-Castro; W Timothy Garvey
Journal:  Endocrinol Metab Clin North Am       Date:  2008-12       Impact factor: 4.741

10.  Glycogen synthase and phosphofructokinase protein and mRNA levels in skeletal muscle from insulin-resistant patients with non-insulin-dependent diabetes mellitus.

Authors:  H Vestergaard; S Lund; F S Larsen; O J Bjerrum; O Pedersen
Journal:  J Clin Invest       Date:  1993-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.